INTRODUCTION
============

DNA in its natural form in the cell is supercoiled. In eukaryotes this state facilitates its organization into chromatin around nucleosomes. DNA topoisomerases control supercoiling and their action is required in replication and transcription as well as in chromosome condensation and segregation ([@gkr840-B1],[@gkr840-B2]). There are two types of DNA topoisomerases (Topo), I and II, which differ in their catalytic way of action, the first relying on a single-strand DNA cleavage, the second on a double-strand break (DSB). Topoisomerases I and II are the most representative of each type in all organisms. They are functionally interchangeable in eukaryotes, but not in bacteria.

During replication DNA topoisomerases can act at different stages. In *Escherichia coli* reconstituted replication systems require DNA supercoiling for replication initiation and the action of DNA topoisomerases ([@gkr840-B3]). However, it is during elongation of replication that topoisomerases are expected to have a key role. They are required to remove the positive supercoiling that are generated by the continuous opening of the template strands. The intertwined daughter DNA molecules resulting after replication completion require the action of type II topoisomerases for their segregation. This late function in replication cannot be performed by type I topoisomerases but only by type II ([@gkr840-B4],[@gkr840-B5]).

In contrast to replication, transcription does not involve a continuous separation of DNA strands. However, RNA polymerase progression through the DNA template would lead to the accumulation of local positive supercoiling ahead of the RNA polymerase and negative supercoiling behind. The twin-supercoiled-domain model was proposed to explain removal of this local supercoiling accumulation by topoisomerases during transcription ([@gkr840-B6]). Evidence for transcriptional supercoiling associated with transcription has been provided in *E. coli* ([@gkr840-B6],[@gkr840-B7]) and yeast ([@gkr840-B8],[@gkr840-B10]). The relaxation of transcription-dependent supercoiling is generally considered to be the main function of Topo I, which is considered to play a swivel role in transcription ([@gkr840-B1],[@gkr840-B2]). In eukaryotes such as the yeast *Saccharomyces cerevisiae*, the fact that *top1Δ* mutants are viable suggests that Topo II can replace the function of Topo I; whereas the opposite is not the case, since Topo I cannot replace Topo II at the end of replication during segregation.

Despite the theoretical bases for the association of topoisomerases and supercoiling changes with transcription, experimental evidence for the impact of topoisomerases deficiency and topological constraints in transcription is incomplete. In bacteria, the importance of Topo I has been well documented in rDNA transcription ([@gkr840-B11]) or transcription from operons involved in amino acid metabolism ([@gkr840-B12],[@gkr840-B13]). In yeast, an effect of topoisomerase activity has been reported on transcription initiation. This may be related to the need of negatively supercoiled DNA at promoter regions to facilitate transcription initiation ([@gkr840-B14]). The effect of DNA topoisomerases on transcription elongation has been established for rDNA, in which the rate of RNAPI transcription is reduced when both DNA topoisomerases are inactivated in yeast ([@gkr840-B8],[@gkr840-B15]). Instead, none or a poor effect has been reported for mRNA transcription as tested in endogenous and *lacZ* reporters fused to *GAL* promoters *in vivo* ([@gkr840-B10],[@gkr840-B16]).

In addition to the effect of Topo mutations in cell growth, transcription and replication, they have an important impact on genome integrity. Stability of tandem rDNA repeats in yeast has been shown to be strongly dependent on DNA topoisomeases I and II, whereas this was not the case for direct repeats outside of the rDNA region ([@gkr840-B17]). Hyper-recombination has been shown in plasmid-borne direct-repeats in double *top1 top2* mutants ([@gkr840-B18]). It has been proposed that this is mainly the result of the failure to relax the negative rather than the positive supercoiling of DNA ([@gkr840-B18]). Nevertheless, impairment of replication fork progression by obstacles or DNA lesions can lead to replication fork collapse that in turn could trigger recombination as a mechanism of replication restart ([@gkr840-B19]). Thus, hyper-recombination of yeast topoisomerase mutants could be linked to their role in replication, but the functional relevance of Topo I in rDNA transcription and its large accumulation in the nucleolus, makes plausible that hyper-recombination could also be linked to transcription. Indeed, rDNA genes contain the RNAPI transcription-dependent *HOT1* recombination hotspots ([@gkr840-B20],[@gkr840-B21]), and one key function of the Fob1 barrier to DNA replication is to avoid replication--transcription collisions that could potentially compromise genome integrity ([@gkr840-B22]).

In this sense, one intriguing class of hyper-recombination mutations in yeast is composed of those of the THO complex. THO is a conserved protein complex composed of stoichiometric amounts of Hpr1, Tho2, Mft1 and Thp2, with a role in transcription elongation, mRNP biogenesis and RNA export ([@gkr840-B23]). THO mutants, as well as mutants related to mRNP biogenesis factors such as the THSC/TREX-2 complex, cause a strong hyper-recombination between direct repeats that are transcription-dependent. This phenotype is linked to the co-transcriptional formation of R-loops that can impair the progression of replication ([@gkr840-B24],[@gkr840-B25]). Interestingly, in *E. coli* mutants lacking topoisomerase I, an excess of negative supercoiling during transcription can lead to R-loops ([@gkr840-B26]). Furthermore, THO and THSC mutants show synthetic growth defects in combination with *top1* and *top2* mutations ([@gkr840-B27]). All this evidence raises the question of whether hyper-recombination in the rDNA region in topoisomerases mutants could be linked to transcription.

Thus, although topological constraints and topoisomerase mutations have a clear impact in expression and stability of the rDNA *locus* this is not that clear for RNAPII transcription and genome integrity at regions others than rDNA. To investigate this, new and highly sensitive *in vivo* assays were developed based on plasmid-borne DNA sequences of increasing lengths that are transcribed form strong promoters with or without convergent transcription coming from a second promoter. We show that both *top1* and *top2* mutations drastically reduce RNAPII transcription, a defect that is strengthened as the length of the transcribed DNA sequence increases and by convergent transcription. Importantly, *top2-1* mutation causes a significant increase in direct-repeat recombination in a *top1Δ* mutant background; however, this hyper-recombination was predominantly independent of transcription of the direct-repeat system itself. Therefore, this study provides new evidence for the *in vivo* relevance of Topos I and II in RNAPII transcription and genome integrity. We propose that DNA topoisomerases has a non-interchangeable role in the maintenance of integrity of RNAPII genes providing evidence for the negative effect of topological constraints in transcription and genome stability in DNA regions beyond the rDNA. Although a similar study would need to be performed in chromosome-borne constructs, we believe that these results may also be valid for chromosomal regions, provided that local supercoiling dynamics follow universal rules.

MATERIALS AND METHODS
=====================

Strains and plasmids
--------------------

Yeast strains and plasmids are described in [Supplementary Tables S1](http://nar.oxfordjournals.org/cgi/content/full/gkr840/DC1) and [S2](http://nar.oxfordjournals.org/cgi/content/full/gkr840/DC1), respectively.

Chromatin immunoprecipitation analysis
--------------------------------------

For ChIP experiments, strains were grown in synthetic medium (SC) 2% glycerol-2% lactate to an OD~660~ of 0.5 (for *GAL1*). For *GAL1* ChIPs the culture was split in two, and one half was supplemented with 2% glucose (repressed transcription) and the other with 2% galactose (activated transcription). For *P~tet~-*based systems, yeast strains were grown in synthetic medium (SC), the culture was split in two, and one half was supplemented with doxycycline. Samples were then taken after 4 h of induction and ChIP assays were performed as described ([@gkr840-B28]). Polyclonal anti-PolII (N-20) (Santa Cruz Biotechnology) and Protein A--Sepharose were used for RNAPII immunoprecipitation. The GFX purification system (Amersham) was used for the last DNA purification step. We used the PCR of the intergenic region at positions 9716--9863 of chromosome V as a negative control. Real-time quantitative PCR and calculations of the relative abundance of each DNA fragment was performed as described ([@gkr840-B29]). For each experiment, the DNA ratios in the different regions were calculated from the DNA amount of these regions relative to the intergenic region. Median and Standard Deviation (SD) of three independent experiments are shown.

Nucleic acid isolation
----------------------

For DNA isolation, pellets were re-suspended to a final concentration of 1.5--2 × 10^9^/ml in NIB pH 7.2 (17% glycerol, 50 mM MOPS, 150 mM KAc, 2 mM MgCl, 0.5 mM spermidine and 0.15 mM spermine) with 3 mg/ml Zymoliase-20T and incubated at room temperature for 25 min. Cellular suspensions were diluted seven times with chilled water and centrifuged to collect nuclei. Pellets were re-suspended in 720 µl of TE (50 mM Tris--HCl, pH 8, 20 mM EDTA) and mixed with 80 µl of 10% SDS. After phenol--chloroform--isoamylalcohol (25:24:1) extraction and ethanol precipitation, DNA was finally re-suspend in 20--30 µl of TE.

Chloroquine gel electrophoresis
-------------------------------

Electrophoresis was performed at room temperature on horizontal slab gels (0.7% agarose) containing TPE buffer (50 mM Tris--phosphate \[pH 7.2\], 1 mM EDTA and 25 mM phosphoric acid). Chloroquine (Sigma) was added to the melted agarose from a 10 mg/ml stock prior to casting the gel and was present in the electrophoresis buffer. The buffer was re-circulated continuously during electrophoresis. The concentration of chloroquine was 4µg/ml. Each lane had 20 µg of total nucleic acids. The gels were run at 40 V for 48 h.

Miscellaneous
-------------

Yeast methods, α-^32^P-labeled DNA probes, northern and Southern analyses were performed according to standard procedures. RNA was isolated from mid-log phase cells.

Recombination frequencies were obtained by fluctuation tests as the median value of six independent colonies isolated from SC plates. The final frequency given for each strain and condition is the mean and SD of three to four median values as described ([@gkr840-B30]). Recombinants Leu+ were selected in SC- Leu plates.

RESULTS
=======

Convergent transcription in systems with or without terminator sequences
------------------------------------------------------------------------

For a fine assessment of the possible effect of topological constraints in transcription, a plasmid-based system was constructed in which a 4-kb sequence was transcribed from two convergent and differentially regulated promoters located on each side. For this construction, we fused a 2-kb *lacZ* fragment under the *GAL1* promoter to a 2-kb *lys2* fragment under the quimeric *tet* promoter so that transcription driven from the two promoters was convergent ([Figure 1](#gkr840-F1){ref-type="fig"}). Two versions of this system were constructed in monocopy *CEN*-based plasmids: one with a 0.4-kb *CYC1* terminator between the *lys2* and *lacZ* sequences (pTGlylaTER) and the other without transcription terminator (pTGlyla). The *CYC1* terminator sequence contains two converging terminators so that it acts in both orientations. As expected, whereas in the pTGlyla system without terminator the 4-kb *lys2-lacZ* mRNA was produced when cells were cultivated either with 2% galactose (*GAL1* promoter activated) or without doxycycline (*tet* promoter activated), but not in 2% glucose + doxycycline (*GAL1* and *tet* promoters repressed) ([Figure 1](#gkr840-F1){ref-type="fig"}A). To confirm that the band detected in 2% galactose was driven from the *GAL1* promoter and the band detected in the absence of doxycycline was driven from the *tet* promoter northern analysis was performed in which hybridization was made with specific ssDNA probes. As expected, the 4-kb mRNA band was specific to a DNA strand. It was detected by the Watson-chain-specific (W) probe in the absence of doxycycline (*P~tet~* active), and with the Crick-chain-specific (C) probe in galactose (*P~GAL1~* active), according to the promoter from which each transcript was transcribed ([Figure 1](#gkr840-F1){ref-type="fig"}B). Instead, in the pTGlylaTER system either the 2-kb *lacZ* or the 2-kb *lys2* mRNAs were detected in galactose regardless of the presence of doxycycline, or in doxycycline regardless of the carbon source, respectively ([Figure 1](#gkr840-F1){ref-type="fig"}C and D). Figure 1.Transcription analyses of the *lys2-CYCt-lacZ* and *lys2-lacZ* fusion constructs. (**A**) Northern analyses of *lys2-lacZ-*containing mRNAs driven from the *tet* and *GAL1* promoters. The 3-kb *Xba*I-*Eco*RV *lacZ* and a 589-bp 25 S rDNA internal fragments obtained by PCR (*rRNA*) were used as DNA probes. (**B**) Northern analyses of *lys2-lacZ*. The oligos C and W were used as single-stranded DNA probes. (**C**), (**D**) Northern analyses of pTGlylaT-1 and pTGlylaT-5 plasmids. Arrows refers to the mRNA being produced from the specified promoter. No arrow indicates that there is no transcription from that promoter. All experiments are made in the absence of doxycycline, so that the *tet* promoter is permanently active. A total of 2% glucose (Glu) or galactose (Gal) are used to either repress or activate the *GAL1* promoter. Other details as described in 'Materials and Methods' section.

Importantly, in the pTGlyla system, the level of 4-kb *lys2-lacZ* transcripts was lower when both the *P~GAL1~* and *P~tet~* promoters were simultaneously active than when only one was active, as observed with either the *lys2* or the *lacZ* probe ([Figure 1](#gkr840-F1){ref-type="fig"}A and B). This result is consistent with transcription interference either at the promoter or transcription stalling provided by RNAPII collisions. Since the 4-kb transcript driven from either the *tet* or *GAL1* promoters reaches the downstream converging promoter, the latter may undergo transcription interference. When the transcripts were analyzed with specific ssDNA probes it was found that after galactose activation the *P~tet~*-driven 4-kb transcript, as detected with the W probe, was reduced, whereas the *P~GAL1~-*driven transcript was below detection levels ([Figure 1](#gkr840-F1){ref-type="fig"}B). This indicates that since the *P~tet~-*driven RNAPII reaches *P~GAL1~*, it causes promoter interference impeding *P~GAL1~* activation, even though transcriptional stalling cannot be excluded either. Similarly, *P~GAL1~-*driven transcription seems to reduce the efficiency of *P~tet~-*driven transcription, although to a lesser extent.

To assay whether the northern results could be interpreted in terms of RNAPII progression, a chromatin--immunoprecipitation (ChIP) analysis was performed with anti-Rpb1 N-ter antibodies in both the pTGlylaTER and pTGlyla systems under all possible conditions (with either none, only one or both promoters activated). As can be seen in [Figure 2](#gkr840-F2){ref-type="fig"}, RNAPII recruitment was not observed in either of the regions analyzed when both promoters were repressed in either system, as expected. In the pTGlylaTER system RNAPII was detected in *lys2* when only *P~tet~* was active and in both *lys2* and *lacZ* when only *P~GAL1~* was active ([Figure 2](#gkr840-F2){ref-type="fig"}A). The latter was consistent with transcription termination read-through observed for transcription initiated at the strong *P~GAL1~* promoter, as observed by northern ([Figure 1](#gkr840-F1){ref-type="fig"}). In the pTGlyla system, RNAPII recruitment was observed at both the *lys2* and *lacZ* regions when either *P~tet~* or *P~GAL1~* were the only active promoters, whereas recruitment to one promoter was only detected when transcription was driven from the opposite promoter ([Figure 2](#gkr840-F2){ref-type="fig"}B), implying that such polymerases corresponded to elongating RNAPIIs. When both promoters were active, the *lys2* and *lacZ* signals were detected, as expected, in the pTGlylaTER system, whereas only the *lys2* signal was detected in pTGlyla. This confirms that the northern analysis used can be interpreted in terms of RNAPII capacity to transcribe the different regions analyzed. Figure 2.Distribution of RNAPII along the *lys2-lacZ* transcription units of plasmids pTGlyla and pTGlylaTER. ChIP analyses in the wild-type strain (HRN1-4A) carrying the plasmids pTGlylaTER (**A**) or TGlyla (**B**). Schemes of the gene and the PCR-amplified fragments are shown. DNA ratios in regions 1--4 were calculated from the amounts obtained for these regions relative to the amounts of the intergenic region. ChIPs were performed from three independent cultures, and quantitative PCRs were repeated three times for each culture. SDs are indicated as error bars.

Transcription elongation is sensitive to Topos I and II inactivation
--------------------------------------------------------------------

Next, the two constructs were used to analyze transcription in the presence of doxycycline, so that the *P~tet~* promoter was inactivated and transcription was only driven from *P~GAL1~*. Under these conditions kinetics experiments were performed of *P~GAL1~*-driven transcription with 2% galactose to determine the efficiency of transcription of the 4-kb *lacZ-lys2* transcript in pTGlyla and the 2-kb *LacZ* transcript in pTGlylaTER. As can be seen in [Figure 3](#gkr840-F3){ref-type="fig"}, transcription of *LacZ* was clearly reduced in *top1Δ* mutants, more reduced in *top2-1* mutants and further in the double *top1Δ top2-1* mutants. Transcription of the 4-kb *lys2-lacZ* was dramatically decreased in all single and double *top* mutants. This result is consistent with a defect in transcription elongation so that the longer the RNA is transcribed the stronger the effect. The double mutant showed the strongest effect and a similar dramatic decrease in the accumulation of both of the 2- and 4-kb transcripts. Figure 3.Transcription analyses of *lys2-CYCt-lacZ* and *lys2-lacZ* fusion transcript driven form the *GAL1* promoter. (**A**) Northern analyses of *lys2-CYCt-lacZ* containing mRNAs driven from the *GAL1* promoter in wild-type (HRN1-4A), *top1Δ* (TOHR-11A), *top2-1* (TORH-6A) and *top1Δ top2-1* (TOHR-13C) strains. Mid-log phase plasmid-transformed cells were diluted in 3% glycerol--2%lactate synthetic complete (SC)-Trp medium plus doxycycline and diluted into identical fresh media to an OD~600~ of 0.4 and incubated for 16 h. Galactose was then added and samples were taken for northern analyses at different times. RNA levels in arbitrary units were obtained by quantification of signals intensities in a FUJI FLA 5000 and normalized with respect to rRNA levels of each sample. Wild-type mRNA levels were taken as 100%. (**B**) Northern analyses of *lys-lacZ-*containing mRNAs driven from the *GAL1* promoter using the same strains as in A.

Different studies have revealed that yeast mutations impairing transcription elongation causes a reduction in mRNA accumulation that in most cases increases with the length of the transcript unit analyzed ([@gkr840-B23]). Using plasmid-borne *P~GAL1~::PHO5* and *P~GAL1~::lacZ* constructs containing the 1.2-kb and 3.1-kb yeast *PHO5* and bacterial *lacZ* ORFs, respectively, under the same *GAL1* promoter, the negative effect of topoisomerase mutations was confirmed in transcription of long DNA sequences. The single and double Topo mutants have a significant effect on the efficiency of transcription of the *PHO5* ORF, the reduction in the accumulation of the *lacZ* mRNA being stronger in the single *top2-1* and in the double *thp1Δ top2-1* ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkr840/DC1)). Given that transcription in both constructs is driven from the same *GAL1* promoter, this result excludes the possibility that the major transcription defects observed in *top* mutants occur at transcription initiation, but at elongation. In addition, consistent with the idea that eukaryotic Topos I and II can partially replace each other, we showed that overexpression of Top1 can partially suppress the *lacZ* mRNA accumulation defect of *top2-1* mutants ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkr840/DC1)).

Convergent transcription is impaired under Topos I and II inactivation as a function of supercoiling accumulation
-----------------------------------------------------------------------------------------------------------------

Next, we assayed whether or not convergent transcription affected transcription efficiency. This analysis of convergent transcription was made in the absence of doxycycline to allow continuous *P~tet~*-driven transcription. Time-course kinetics was performed for the *P~GAL1~*-driven transcripts after galactose addition. As can be seen in [Figure 4](#gkr840-F4){ref-type="fig"}, in the pTGlylaTER system with the transcription terminator the overall levels of the *P~tet~-*driven *lys2* transcript did not show a significant change after activation of the converging *P~GAL1~*. At 200 min of *P~GAL1~* activation the overall levels of *lys2* transcripts were similar to the levels before activation. At intermediate times some differences between wild-type and mutant strains were evident, but these were minor. This may be a response to cell adaptation to new conditions. Importantly, at 200 min of activation the *lys2* transcript levels were the same in wild-type and mutant strains, with a slight decrease in *top1Δ top2-1* mutants. Instead, transcription from the *GAL1* promoter, as determined by accumulation of the 2-kb *lacZ* transcript, was clearly affected in *top1Δ* and *top2-1* mutants (38--40% of wild-type levels) and much more in the double *top1Δ top2-1* mutants (10% of wild-type levels) ([Figure 4](#gkr840-F4){ref-type="fig"}A). The clear impairment in transcription of the 2-kb *lacZ* transcript caused by topoisomerase mutations as compared to the poor or no effect on the 2-kb *lys2* transcript (both transcripts are of the same size but are driven from promoters of different strengths), indicates that the higher the transcription rate the higher the requirement of topoisomerases. Figure 4.Northern analyses of convergent transcription in the *lys2-CYCt-lacZ* and *lys2-lacZ* fusion constructs. (**A**) Northern analyses of *lys2-CYCt-lacZ* mRNAs driven from the *tet* and *GAL1* promoters in wild-type (HRN1-4A), *top1Δ* (TOHR-11A), *top2-1* (TORH-6A) and *top1Δ top2-1* (TOHR-13C) strains. The 3-Kb *Xba*I-*Eco*RV *lacZ* internal fragment were used as DNA probe. (**B**) Northern analyses of *lys2-lacZ* mRNAs driven from the *P~tet~* and *P~GAL1~* promoters. Other details as described for [Figure 3](#gkr840-F3){ref-type="fig"}.

In the pTGlyla system there is little change in the total amount of 4-kb transcripts ([Figure 4](#gkr840-F4){ref-type="fig"}B) during the kinetics performed. As shown above, these results indicate that pTGlyla, which contains no terminator sequence between the converging promoters, undergoes promoter interference caused at *P~GAL1~* by the RNAPII coming from *P~tet~*. However, despite the interference phenomenon, transcripts were moderately low in single *top1* and *top2* mutants (60--65% of wild-type levels after 200 min activation) and lower in double *top1 top2* mutants (38--45%) as compared to wild-type levels. This is consistent with the importance of topoisomerase activities in converging transcription. It is worth noting the different topoisomerase requirements of transcription of the 4-kb *lys2-lacZ* and 2-kb *lys2* fragments in the pTGlyla and pTGlylaTER systems (compare [Figures 4](#gkr840-F4){ref-type="fig"}A. up and D, bottom). This is due to the longer length of the *lacZ-lys2* fragment, consistent with the conclusion that the longer the transcript the higher the dependency of transcription on topoisomerase activity ([Figure 1](#gkr840-F1){ref-type="fig"}). Altogether, the results indicate that topoisomerases I and II are required for efficient RNAPII transcription elongation.

To assay whether the transcription defect caused by *top* mutations was linked to the incapacity to resolve supercoiling, rather than to a specific function of any of the topoisomerases at specific target DNA sites, supercoiling of the plasmids was analyzed carrying both the pTGlylaTER and pTGlyla systems under conditions of transcription activation of both promoters. As can be seen in [Figure 5](#gkr840-F5){ref-type="fig"}, a large proportion of supercoiled DNA is accumulated in *top* mutants, in particular in *top1* and *top1 top2* when both promoters are active, but not when they were inactive. Experiments were performed similarly to previous reports using chloroquine concentrations in which all topoisomers show negative supercoiling ([@gkr840-B9]). Importantly, accumulation of the supercoiled plasmid band is clearly stronger in pTGlyla versus pTGlylaTER, consistent with the conclusion that the longer the length of the transcription unit, the higher the change in supercoiling produced by transcription and the stronger the requirement of topoisomerases. Even though on a theoretical basis the impact of transcription on DNA supercoiling is local, *TOP1* inactivation has a global impact on plasmid supercoiling as has been previously reported ([@gkr840-B9]). As previously shown ([@gkr840-B9]) accumulation of global supercoiling was not evident in *top2-1* mutants. Figure 5.Analysis of the effect of *top1Δ* and *top2-1* on DNA supercoiling. (**A**) Chloroquine gel electrophoresis analysis of plasmid pTGlylaTER in wild-type (HRN1-4A), *top1Δ* (TOHR-11A), *top2-1* (TORH-6A) and *top1Δ top2-1* (TOHR-13C). Strains were cultured under non-transcription conditions in glucose plus doxycycline (Glu +dox) and under transcription conditions in galactose without doxycycline (Gal) at 30°C. Electrophoresis was carried out in the presence of 4 µg/ml chloroquine, and hybridization was performed with a labelled *LYS2* DNA probe. Southern reveals bands representing topoisomers differing in linking number by steps of one. With the chloroquine concentration used, all topoisomers are negatively supercoiled, with those of increasing negative superhelicity migrating faster in the gel. The band marked as SC consists of the most negatively supercoiled species that are not resolved by the concentration of chloroquine used here. (**B**) Chloroquine gel electrophoresis analysis of plasmid pTGlyla.

Efficient RNAPII-driven convergent transcription requires Topos I and II
------------------------------------------------------------------------

So far, all our previous experiments were performed at 30°C, a semi-permissive temperature to allow growth of *top2-1* thermosensitive mutants. Yet, it was possible to see a synergistic effect on double *top1 top2* mutants suggesting that Topo II has a role in transcription *in vivo*. This conclusion was confirmed by assaying the effect on complete Top II inactivation. These experiments were repeated on convergent transcription in both the pTGlyla and pTGlylaTER systems after shifting cells to the restrictive temperature of 37°C. As can be seen in [Figure 6](#gkr840-F6){ref-type="fig"}A, in the pTGlylaTER system in which both convergent promoters are activated, whereas *lys2* and *lacZ* transcript levels show little effect on *top1Δ* and *top2-1* single mutants, which were dramatically reduced in the double *top1Δ top2-1* mutants (20% of wild-type levels after 2 h at 37°C). In the pTGlyla system, whereas in wild-type and, to a lesser extent, in the *top1Δ* mutant, the 4-kb transcript levels increased with time at 37°C consistent with a faster metabolism at this temperature, they did not change in *top2-1* mutants and dropped dramatically in *top1Δ top2-1* mutants ([Figure 6](#gkr840-F6){ref-type="fig"}B). These results were confirmed by analyzing the effect of *top2-1* at different temperatures, from 30°C to 33°C in which it could be seen a dramatic decrease in the accumulation of *lacZ* mRNA in the *top1Δ* background as the temperature increased ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkr840/DC1)). Altogether, the results indicate that Topo II plays a critical role in RNAPII transcription *in vivo*, which indeed is quantitatively more important than that of Topo I. Figure 6.Effect of *top1* and *top2* mutations on transcription of *lys-CYCt-lacZ* and *lys-lacZ* fusion constructs at 37°C. (**A**) Northern analyses of *lys-CYCt-lacZ-*containing mRNAs driven from the *tet* and *GAL1* promoters in wild-type (HRN1-4A), *top1Δ* (TOHR-11A), *top2-1* (TORH-6A) and *top1Δ top2-1* (TOHR-13C) strains at 37°C. Mid-log phase plasmid-transformed cells were diluted to an OD~600~ of 0.4 synthetic complete (SGal)-Trp medium at 26°C and shifted to 37°C, samples were taken for northern analyses at different times. (**B**) Northern analyses of *lys-lacZ* mRNAs driven from the *P~tet~* and *P~GAL1~* promoters. Other details as described in [Figure 3](#gkr840-F3){ref-type="fig"}.

*top1Δ* and *top2-1* confer a general hyper-recombination phenotype
-------------------------------------------------------------------

It is known that *top1Δ* mutants confer a strong hyper-recombination at the rDNA *locus* ([@gkr840-B17]). To test whether this lack of effect was general for any DNA region and for different types of recombination events and whether it was related to transcription, the effect of *top* mutations on recombination was analyzed in different and highly sensitive plasmid-borne recombination systems. First we assayed recombination in the pTINV system based on two inverted repeats of the *LEU2* gene, one copy of which is a 5′-end truncation (*leu2Δ5′*) and the other a 21-bp insertion mutation under the control of the regulated *tet* promoter (*P~tet~::leu2-HOr*) ([@gkr840-B31]). This system allows detection of gene conversion events of the *leu2-HOr* allele with or without crossovers as a function of transcription, which leads to Leu+ recombinants that are scored on SC-leu plates ([Figure 7](#gkr840-F7){ref-type="fig"}A). As can be seen in [Figure 7](#gkr840-F7){ref-type="fig"}A, whereas Leu+ recombination levels in *top1Δ* and *top2-1* mutants were similar to the wild-type both with or without transcription, recombination was increased 26- and 37-fold without or with transcription. Next, we tested the effect on recombination in the pGL-PHO5 system carrying two 0.6-kb *leu2* direct repeats under the control of the *GAL1* promoter and the *PHO5* ORF located between the repeats ([@gkr840-B32]).This system is used to study deletions occurring by recombination between the two *leu2* direct repeats that are scored as Leu+ colonies ([Figure 7](#gkr840-F7){ref-type="fig"}B). It can be used either with active transcription of the direct-repeat construct in media supplemented with 2% galactose or without transcription in media with 2% glucose. Leu+ deletions occurred at similar levels in *top1Δ* and *top2-1* mutants as in the wild-type, whereas in *top1Δ top2-1* mutants there was a significant increase in recombination both with or without transcription (15- and 10-fold increase, respectively) ([Figure 7](#gkr840-F7){ref-type="fig"}B). These data indicate that only a simultaneous defect of topoisomerases I and II lead to a general increase in recombination, which is primarily independent of transcription of the DNA sequences involved in the recombination event. Similar results were observed with the pGL-lacZ system ([@gkr840-B32]), the same as pGL-PHO5 with *LacZ* between the *leu2* repeats ([Figure 7](#gkr840-F7){ref-type="fig"}C). A clear increase in recombination was observed in *top1 top2* mutants with or without transcription (7.2- and 11-fold increase). However, it is worth noting that a significant increase (4.2-fold) was also observed in single *top1* mutants but only under transcription conditions, suggesting that the torsional stress caused by transcription elongation through the *lacZ* sequence is recombinogenic in the absence of Topo I. Figure 7.Recombination analyses of wild-type, *top1Δ*, *top2-1* and *top1Δ top2-1* strains. (**A**) Recombination between inverted repeat in plasmid pRS316-TINV carrying two inverted *leu2* sequences. One copy is the *leu2-HOr* allele under the *tet* promoter and the other is a 5′-end truncated allele (*leu2Δ5′*). Transcription of *leu2* is driven from *tet* promoter. Leu^+^ recombinants can arise by gene conversion of *leu2-HOr* without an associated inversion or by crossover occurring upstream of the HO site, whether or not associated with gene conversion. (**B**) Recombination between directs repeats in the system *GL::PHO5* carrying a 600-bp truncated *leu2* repeat under the *P~GAL1~* promoter*.* Leu^+^ recombinants can arise by the deletion of the *PHO5* sequence. (**C**) Recombination between directs repeats in the system *GL::LacZ* carrying 600-bp truncated *leu2* repeats under the *P~GAL1~* promoter*.* Leu^+^ recombinants arise by the deletion of the *LacZ* sequence.

To test whether hyper-recombination could also be observed in direct-repeat systems containing the TGlyla and TGlylaTER converging transcription systems, new plasmid-borne recombination systems were constructed by inserting the TGlyla and TGlylaTER constructs between the two 0.6-kb *leu2* direct-repeats of the plasmid-borne L repeat construct previously published ([@gkr840-B33]) to create the recombination systems L-lyla and L-lylaTER ([Figure 8](#gkr840-F8){ref-type="fig"}). The frequency of Leu+ deletions was determined under conditions in which none (media with glucose and doxycycline), only one (with galactose and doxycycline or glucose without doxycycline) or both (with galactose without doxycycline) promoters were activated. As can be seen in [Figure 8](#gkr840-F8){ref-type="fig"}A, a 3.4- to 5.6-fold increase in Leu+ deletions was observed in the double *top1Δ top2-1* mutants under the four different conditions of transcription tested as well as in the single *top1Δ* mutant when *GAL1p*-driven transcription was active, regardless of transcription from the *tet* promoter. Similar results were observed in the L-lylaTER ([Figure 8](#gkr840-F8){ref-type="fig"}B). In these cases, a 3.3- to 12-fold increase in recombination was observed in the double mutant *top1Δ top2-1* in the four conditions, the major effect being observed when both promoters were active. A weaker effect could be seen in single *top1Δ* mutants. Altogether, these results indicate that only a simultaneous defect of topoisomerases I and II lead to a general increase in recombination, and this effect is primarily independent of transcription of the DNA repeats and their intervening DNA sequences involved in the recombination event. Figure 8.Recombination analyses of wild-type, *top1Δ*, *top2-1* and *top1Δ top2-1* strains in DNA substrates undergoing converging transcription. (**A**) Recombination frequencies were determined in wild-type (HRN1-4A), *top1Δ* (TOHR-11A), *top2-1* (TORH-6A) and *top1Δ top2-1* (TOHR-13C) strains transformed with plasmid pLlyla carrying the direct-repeat system L-Llyla in which transcription is under the *P~LEU2~* promoter. (**B**) Recombination frequencies in wild-type (HRN1-4A), *top1Δ* (TOHR-11A), *top2-1* (TORH-6A) and *top1Δ top2-1* (TOHR-13C) strains transformed with plasmid pLlylaTER carrying the direct-repeat system L-LlylaTER. For more details see 'Materials and Methods' section.

In this sense, mutations in the THO complex, such as *hpr1Δ*, cause a strong increase in direct-repeat recombination that is linked to transcription. As Topo mutations lead to weaker hyper-recombination that is not restricted to direct-repeat systems and mainly in a transcription-independent manner, it seemed reasonable that both type of mutations may affect recombination via different pathways. To test this possibility recombination in the L-lyla system was analyzed in double mutant combinations of *hpr1Δ* with *top1Δ* and *top2-1* mutations. As can be seen in [Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkr840/DC1), hyper-recombination was clearly observed in *hpr1Δ* mutants under *P~tet~* or *P~GAL1~-*driven transcription (12- to 15-fold), but to a lesser extent when both the *tet* and *GAL1* promoters were inactive. The triple mutant *hpr1Δ top1Δ top2-1* shows a synergistic effect on hyper-recombination that reached 47- to 71-fold increase when only one promoter was active, and 123-fold when both promoters were active. Although we cannot exclude that transcription outside of the DNA recombination construct in the plasmid could influence the general levels of recombination due to its global impact on plasmid supercoiling, our result shows that, in contrast to THO--complex mutations, the effect of Topos I and II mutations in non-rDNA recombination is primarily not linked to transcription of the recombination system.

DISCUSSION
==========

Here we show that Topos I and II play a role in eukaryotic RNAPII-driven transcription and genome stability in the yeast *S. cerevisiae*. RNAPII transcription requires Topos I and II at the elongation step, this being the role of Topo II in elongation independent of Topo I and of supercoiling accumulation. Notably, the impact of supercoiling accumulation in genome instability is not related to transcription of the direct-repeat in which instability is measured. Consequently, our work reveals independent effects of the overlapping functions of Topos I and II in transcription and genome integrity. In addition, we show that a promoter cannot be efficiently activated if the anti-sense DNA strand is transcribed, a result that suggests new possibilities to explain regulation of gene expression by promoter interference.

RNAPII transcription elongation impairment by topological constraints *in vivo*
-------------------------------------------------------------------------------

The relevance of topoisomerases and supercoiling constraint in transcription was anticipated and demonstrated in the past in prokaryotic and eukaryotic cells ([@gkr840-B2],[@gkr840-B5]). Different reports have shown that the levels of DNA supercoiling have an impact in RNA synthesis in *E. coli* ([@gkr840-B34],[@gkr840-B35],[@gkr840-B36]). Requirement of DNA topoisomerases in transcription can be explained by the twin-supercoiled-domain model ([@gkr840-B6]). The negative impact of failure to control DNA supercoiling in transcription is believed to be linked to the transcription elongation step. Evidence for this has been provided in the rDNA regions, as in yeast ([@gkr840-B2],[@gkr840-B14]). Other studies of transcription at the rDNA region in human cells are consistent with this view ([@gkr840-B37]). In yeast, it has also been shown that positive supercoiling diminishes mRNA transcription, probably at the initiation step ([@gkr840-B15]). In human cells it has been shown that DNA topoisomearse I is involved in both repression and activation of transcription ([@gkr840-B38]), providing evidence that DNA supercoiling can also control transcription initiation. All these data plus the observation that yeast topoisomerase mutants accumulate transcription-dependent supercoiling ([@gkr840-B9]) indicates that this supercoiling needs to be removed by the action of DNA topoisomerases to allow transcription. Whereas the transcriptional role of Topo I has been previously documented, no evidence has been reported for a role of Topo II in RNAPII transcription *in vivo*, despite the fact that Topos I and II are redundant in eukaryotes. Evidence for a role of Topo II in RNAPII transcription has been shown in chromatin templates *in vitro* ([@gkr840-B39]). In addition, despite the expectation that transcription elongation should be sensitive to supercoiling, according to the twin-supercoiled-domain model, experimental evidence for the negative effect that supercoiling may have in RNAPII-driven transcription elongation was lacking.

Our study on RNAPII transcription has been based on two convergent transcription units. Convergent transcription should create a local accumulation of positive supercoiling ahead of each polymerase that would quickly accumulate in topoisomerases mutants. Our work shows that, indeed, convergent transcription is reduced when both promoters are active in both single *top1* and *top2* mutants. Such a reduction in transcription efficiency is synergistic in double mutants *top1 top2*, in which transcription is reduced to almost undetectable levels*.* The results reveal a role for Topo II in transcription. It is likely that Topo II function has a minor impact in wild-type cells expressing Topo I. Nevertheless, our result suggests that Topo2 can replace Topo I in transcription when the latter is absent in the cell. This negative effect of Topo mutations on transcription is seen when the length of the mRNA is 4 or 2 kb, which likely indicates that 2-kb of transcription run is already sufficient to see the effect of supercoiling accumulation in transcription. Interestingly, transcription in simple systems in which transcription is only unidirectional, no effect of topoisomerases mutations is observed for 1.2-kb transcript units, but only in 3-kb long transcription units, even though this effect is clearly lower than for convergent transcription. This is consistent with a major impact of convergent transcription on local DNA supercoiling and with the idea that the longer the DNA sequence transcribed the higher the supercoiling. The impact in supercoiling has been shown indeed by chloroquine gels, as expected from previous work ([@gkr840-B9]) ([Figure 5](#gkr840-F5){ref-type="fig"}). Although we cannot exclude the possibility that the reduction in transcription efficiency could be determined at the level of transcription initiation, altogether the data indicate that transcription elongation is a major step impaired by supercoiling accumulation. Accordingly with, we have been able to observe a synergistic effect on transcription efficiency in a *top1 top2* mutant carrying a deletion of the *SPT4* elongation factor gene in the 1.2-kb transcript. This indicates that under impaired transcription elongation, supercoiling accumulation has a negative impact on transcription elongation ([Supplementary Figure S4](http://nar.oxfordjournals.org/cgi/content/full/gkr840/DC1)).

Therefore, our work shows that mRNA transcription is strongly impaired by topoisomerase inactivation and supercoiling accumulation. Both Top2 and Top1 play important roles in removing superhelicity during transcription. Therefore, Top2 not only substitutes for Top1 to control supercoiling accumulation during transcription elongation, but it also plays a function in wild-type cells, consistent with its reported roles in RNAPII transcription in chromatin templates ([@gkr840-B39]). Interestingly it has recently been shown that Topo2 is required to relax nucleosomal DNA ([@gkr840-B40]) and for rDNA transcription in yeast ([@gkr840-B2]). Further investigation would be necessary to define how Top2 acts during transcription, and whether its role is only related to supercoiling accumulation, given the fact that under the conditions studied no strong accumulation of DNA supercoiling is observed in *top2* mutants in contrast to *top1* mutants ([Figure 5](#gkr840-F5){ref-type="fig"}).

It is worth noting that our assays provide an example in which promoter interference has a negative impact on the ability of a promoter to be activated. Thus, when the *GAL1* promoter was active, in which case the anti-sense DNA strand of the *tet* promoter was transcribed, the *tet* promoter could not be efficiently activated. This suggests that promoter transcription interferes with its activity, opening the possibility that promoter inactivation by CUTs or anti-sense RNAs ([@gkr840-B41],[@gkr840-B42]) might also be caused by transcription, which could presumably disrupt the proteins and architecture of a functional promoter.

Direct-repeat hyper-recombination in topoisomerase-defective cells
------------------------------------------------------------------

Previous evidence has shown that rDNA stability was highly dependent on DNA topoisomerases I and, to a lesser extent, on Topo II ([@gkr840-B17]). Short circular plasmids carrying non-rDNA regions have been shown to suffer frequent multimerization in yeast Topo mutants ([@gkr840-B43]). Although multimerization is attributed to recombination, no study has been performed on whether such multimerization could be due to replication impairment leading to re-initiation and/or sigma-like type of replication due to enhanced superhelicity. The fact that this is observed in short circles indicate a specific structural demand, presumably associated with changes in supercoiling that may not be related only to recombination. The increased in recombination observed in our systems is in any case lower and not accompanied by multimerization.

A different study using direct-repeat systems such as those used in this study, revealed increases in direct-repeat recombination of 40- to 100-fold only in *top1 top2* mutants ([@gkr840-B18]). An important difference between those direct-repeats did not contain DNA sequences between the tandem direct repeats whereas the systems used in this study contained between 2 and 4 kb. This may explain why in our case at most we get a 10-fold increase in recombination. We previously showed that the distance between the repeats has an impact on recombination: the longer the intervening sequence the higher the probability that recombination events are initiated there ([@gkr840-B33]). Long repeats may have a steric impediment that would interfere with a proper pairing of the two repeats along their length, whereas such steric limitations may not exist when the distance between the repeats is longer than the repeat units. Failure to relax negative supercoiling might limit pairing of both DNA repeats. Interestingly, however, our study reveals that topoisomerase depletion strongly increases gene conversion (37-fold). As it seems plausible that gene conversion is mainly initiated by DSBs, our study suggests therefore a general impact of negative supercoiling on genome fragility linked to DNA breaks.

Given the impact of Topo depletion on transcription in general and transcription of the convergent constructs used in this study in particular, it is notable that the increase in recombination is not linked to the increase in the levels of transcription of the direct repeat itself. Even when convergent transcription is activated between the two direct repeats, with or without a transcription terminator in between, hyper-recombination is not significantly affected. This implies that the hyper-recombination caused by topoisomerase inactivation is not caused by breaks that might occur as a consequence of local conflicts generated between transcription and replication. This may contrast with the hyper-recombination in the rDNA ([@gkr840-B8]).

In non-rDNA regions, evidence has recently shown that in human cells Top1 prevents replication obstacles in transcribed sequences, suggesting that such obstacles are mediated by R-loops ([@gkr840-B44]). Indeed it has recently been shown in yeast that R-loops form in yeast cells deleted for *TOP1* ([@gkr840-B45]), consistent with previous work in *E. coli* showing R-loop accumulation in the rDNA in *topA* mutants ([@gkr840-B26]). Even though it seems clear that transcribed regions are more prone to obstacles, and recombination in our assays are determined in transcribed genes, our data clearly shows that the topological constrains generated in topoisomerases mutants causes instability in DNA regions that are not transcribed either. In our systems in particular, hyper-recombination is observed in the direct repeat regardless of whether or not is transcribed. Another report in yeast ([@gkr840-B46]) showed that Top2 prevents chromosome fragility in regions that are transcribed during S phase. Again, we are able to observe hyper-recombination even in the absence of transcription. Therefore, there are two possibilities, either the chromosome fragility reported in human and yeast in *top1* or *top2* cells caused by replication impairment in transcribed DNA regions is not resolved primarily by detectable homologous recombination or if they are, transcription-dependent recombination only reflects a minor fraction of chromosome fragility generated by topoisomerase inactivation. The strong impact of topoisomerase inactivation on replication progression would therefore be sufficient to generate the hyper-recombination phenotype observed in *top1 top2* mutants. This would fit the expected role of topoisomerases in regulating DNA supercoiling changes occurring during replication fork progression ([@gkr840-B4],[@gkr840-B5]). Failure to resolve this supercoiling accumulation may cause replication stalls that can resolve in ssDNA breaks or gaps.

Our results exclude the possibility that a co-transcriptional R-loop that could putatively form at the direct repeats could be responsible for recombinogenic breaks. Global supercoiling of the plasmid may also be affected by transcription of DNA regions away from the direct repeat used for the analysis of recombination, but whether such a transcriptional activity influences at distance the levels of recombination of the direct repeat we cannot be certain. However, given the low levels of transcription of the plasmid marker as compared to the high transcript levels of the direct-repeat recombination system driven from the *GAL1* promoter, this is an unlikely possibility. In any case recombination would not initiate at the transcribed plasmid marker but away of it in the non-transcribed direct repeat. For the same reason, an R-loop putatively formed in the plasmid outside the direct-repeat recombination system would not be expected to induce the high levels of recombination determined in this study. In conclusion, the genome instability phenotype of Topo mutants does not require transcription of the sequence involved in the recombination event.
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